FTC says pharmacy benefit managers are stonewalling requests for information; Viking Therapeutics obesity drug hits target in key study

Taking stock of the drug industry, from the lab to the medicine chest

February 27, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

APStock STAT+ | FTC says pharmacy benefit managers are stonewalling requests for information The delay angered U.S. Sen. Chuck Grassley (R-Iowa), who has been pushing to change pharmacy benefit manager business practices. By Ed Silverman STAT+ | Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines Shares of the San Diego company more than doubled in premarket trading on the news of the successful Phase 2 study. By Andrew Joseph STAT+ | FDA protocols originally intended to be extra conservative are now heralded as evidence of mifepristone's risk Cautious protocols adopted 20 years ago by the FDA in its approval of the abortion pill are now being touted as evidence of its dangers. By Olivia Goldhill Adobe STAT+ | Experts say scale of Change cyberattack shows risk of centralized claims processing Change Health connects 900,000 physicians, 33,000 pharmacies, and 5,500 hospitals. Security experts say concentrated services present concentrated risks. By Brittany Trang and Tara Bannow and Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser